Thus, a suppression of ADA activity may help improve insulin sensitivity and inflammation, cell proliferation, and T-lymphocyte activity, all of which are putatively associated with the pathophysiology of T2DM. This evidence concerns the gene ADA and type 2 diabetes mellitus.